Project Details
Description
A Phase 1/2 Study of SL-701, A Subcutaneously Injected Multivalent Glioma-Associated Antigen Vaccine, in Adult Patients with Recurrent Glioblastoma Multiforme
| Status | Finished |
|---|---|
| Effective start/end date | 5/1/14 → 5/30/19 |
Funding
- STEMLINE THERAPEUTICS, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.